Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy

Acta Pharmacologica Sinica

Volumn 25, Issue 12, 2004, Pages 1569-1575

  Huang, Xu Pei ^a   Du, Jian Feng ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Cardiology; Contractile proteins; Diastole; Genetically modified animals; Missense mutation; Restrictive cardiomyopathy; Troponin I

Indexed keywords

TROPONIN I;

DIASTOLE; DISEASE ASSOCIATION; GENE MUTATION; HEART DISEASE; HEART FUNCTION; HUMAN; MOLECULAR GENETICS; MOUSE; NONHUMAN; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOMERE; THIN FILAMENT;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; DIASTOLE; HUMANS; MUTATION; TROPONIN I;

EID: 10344228251     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
2. Chen J, Chien KR. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J Clin Invest 1999; 103: 1483-5.
3. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-2.
4. Fatkin D, Graham RM. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 2002; 82: 945-80.
5. 2+ regulation of muscle contraction. Biochemistry 1974; 13: 2697-703.
6. Hitchcock SE. Regulation of muscle contraction: bindings of troponin and its components to actin and tropomyosin. Eur J Biochem 1975; 52: 255-63.
7. Hartshorne DJ, Mueller H. Fractionation of troponin into two distinct proteins. Biochem Biophys Res Commun 1968; 31: 647-53.
8. Schaub MC, Perry SV. The relaxing protein system of striated muscle. Resolution of the troponin complex into inhibitory and calcium ion-sensitizing factors and their relationship to tropomyosin. Biochem J 1969; 115: 993-1004.
9. Greaser ML, Gergely J. Reconstitution of troponin activity from three protein components. J Biol Chem 1971; 246: 4226-33.
10. Perry SV, Cole H, Head JF, Wilson FJ. Localization and mode of activation of the inhibitory protein component of the troponin complex. Cold Spring Harbor Symp Quant Biol 1972; 37: 251-62.
11. Weeks RA, Perry SV. Characterization of a region of the primary sequence of troponin C involved in calcium ion-dependent interaction with troponin I. Biochem J 1979; 173: 449-57.
12. Chong PCS, Asselbergs PJ, Hodges RS. Inhibition of rabbit skeletal muscle acto-S1 ATPase by troponin T. FEBS Lett 1983; 153: 372-6.
13. Syska H, Wilkinson JM, Grand RJ, Perry SV. The relationship between biological activity and primary structure of troponin I from white skeletal muscle of the rabbit. Biochem J 1976; 153: 375-87.
14. Talbot JA, Hodges RS. Synthesis and biological activity of an icosapeptide analog of the actomyosin ATPase inhibitory region of troponin I. J Biol Chem 1979; 254: 3720-3.
15. Talbot JA, Hodges RS. Synthetic studies on the inhibitory region of rabbit skeletal troponin I. Relationship of amino acid sequence to biological activity. J Biol Chem 1981; 256: 2798-802.
16. van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ. Breakdown and release of myofilament protein during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res 1998; 82: 261-71.
17. Ngai SM, Hodges RS. Structural and functional studies on troponin I and troponin C interactions. J Cell Biochem 2001; 83: 33-46.
18. Noland TA Jr, Raynor RL, Kuo JF. Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J Biol Chem 1989; 264: 20778-86.
19. 2+-stimulated actomyosin MgATPase activity. J Biol Chem 1991; 266: 4974-8.
20. Noland TA Jr, Kuo JF. Protein kinase C phosphorylation of cardiac troponin I and troponin T inhibits Ca(2+)-stimulated MgATPase activity in reconstituted actomyosin and isolated myofibrils, and decreases actin-myosin interactions. J Mol Cell Cardiol 1993; 25: 53-65.
21. Westfall MV, Solaro RJ. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res 1992; 70: 302-13.
22. Gao WD, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 1997; 80: 393-9.
23. van Eyk JE, Hodges RS. The biological importance of each amino acid residue of the troponin I inhibitory sequence 104-115 in the interaction with troponin C and tropomyosin-actin. J Biol Chem 1988; 236: 1726-32.
24. Toyo-Oka T, Ross J. Ca sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion. Am J Physiol 1981; 240: H704-H708.
25. McDonogh JL, Labugger R, Pickett W, Tse MY, MacKenzie S, Pang SC, et al. Cardiac troponin I is modified in the myocardium of bypass patients. Circ Res 2001; 103: 58-64.
26. Foster DB, Van Eyk JE. In search of the proteins that cause myocardial stunning. Circ Res 1999; 85: 470-2.
27. Kusuoka H, Marban E. Cellular mechanisms of myocardial stunning. Annu Rev Physiol 1992; 54: 243-56.
28. Murphy H, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, et al. Transgenic mouse model of stunned myocardium. Science 2000; 287: 488-91.
29. Thomas SA, Fallavollita JA, Lee TC, Feng J, Canty JM Jr. Absence of troponin I degradation or altered sarcoplasmic reticulum uptake protein expression following reversible ischemia in swine. Circ Res 1999; 85: 446-56.
30. Sherman AJ, Klocke FJ, Decker RS, Decker ML, Kozlowski KA, Harris KR, et al. Myofibrillar disruption in hypocontractile myocardium showing perfusion-contraction matches and mismatches. Am J Physiol Heart Circ Physiol. 2000; 278: H1320-34.
31. Saggin L, Gorza L, Ausoni S, Schiaffino S. Troponin I switching in the developing heart. J Biol Chem 1989; 264: 16299-302.
32. Bhavsar PK, Dhoot GK, Gumming DV, Butler-Browne GS, Yacoub MH, Barton JR. Developmental expression of troponin I isoforms in fetal human heart. FEBS Lett 1991; 292: 5-8.
33. Schianffino S, Gorza L, Ausoni S. Troponin isoform switching in the developing heart and its functional consequences. Trends Cardiovasc Med 1993; 3: 12-7.
34. Gorza L, Ausoni S, Merciai N, Hastings KE, Schiaffino S. Regional differences in troponin I isoform switching during rat heart development. Dev Biol 1993; 156: 253-64.
35. Sasse S, Brand NJ, Kyprianou P, Dhoot GK, Wade R, Arai M, et al. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res 1993; 72: 932-8.
36. 2+-regulatory site of bovine cardiac troponin. J Biol Chem 1982; 257: 260-3.
37. 2+ affinity of cardiac troponin C. J Biol Chem 1995; 270: 30773-80.
38. Chandra M, Dong WJ, Pan BS, Cheung HC, Solaro RJ. Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C. Biochemistry 1997; 36: 13305-11.
39. Westfall MV, Rust EM, Metzger JM. Slow skeletal troponin I gene transfer, expression, and myofilament incorporation enhances adult cardiac myocyte contractile function. Proc Natl Acad Sci USA 1997; 94: 5444-9.
40. Fentzke RC, Buck SH, Patel JR, Lin H, Wolska BM, Stojanovic MO, et al. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol 1999; 517: 143-57.
41. Arteaga GM, Palmiter KA, Leiden JM, Solaro RJ. Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J Physiol 2000; 526: 541-9.
42. Wolska BM, Vijayan K, Arteaga GM, Konhilas JP, Phillips RM, Kim R, et al. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol 2001; 536: 863-70.
43. Wade R, Eddy R, Shows TB, Kedes L. cDNA sequence, tissue-specific expression, and chromosomal mapping of the human slow-twitch skeletal isoform of troponin I. Genomics 1990; 7: 346-57.
44. Corin SJ, Juhasz O, Zhu L, Conley P, Kedes L, Wade R. Structure and expression of the human slow twitch skeletal muscle troponin I gene. J Biol Chem 1994; 269: 10651-9.
45. Boheler KR, Schwartz K. Gene expression in cardiac hypertrophy. Trends Cardiovasc Med 1992; 2: 172-8.
46. Morkin E. Control of cardiac myosin heavy chain gene expression. Microscopy Res Tech 2000; 50: 522-31.
47. Huang XP, Lee KJ, Riedel B, Zhang C, Lemanski LF, Walker JW. Thyroid hormone regulates slow skeletal troponin I gene inactivation in cardiac troponin I null mouse hearts. J Mol Cell Cardiol 2000; 32: 2221-8.
48. Gumming DV, Seymour A, Rix LK, Kellett R, Dhoot GK, Yacoub MH, et al. Troponin I and T protein expression in experimental cardiac hypertrophy. Cardioscience 1995; 6: 65-70.
49. Ricchiuti V, Zhang J, Apple FS. Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling. Clin Chem 1997; 43: 990-5.
50. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953-8.
51. Welsh TM, Kukes GD, Sandweiss LM. Differences of creatine kinase MB and cardiac troponin I concentrations in normal and diseased human myocardium. Ann Clin Lab Sci 2002; 32: 44-9.
52. Huang XP, Pi Y, Lee KJ, Henkel AS, Gregg RG, Powers PA, et al. Cardiac troponin I gene knockout: a mouse model of myocardial troponin I depletion. Circ Res 1999; 84: 1-8.
53. Jia Y, Akerman S, Huang XP. Myofibril MgATPase activities and energy metabolism in cardiomyopathic mice with diastolic dysfunction. J Biomed Sci 2004; 11: 450-6.
54. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echo-cardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults. Circulation 1995; 92: 785-9.
55. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 1999; 44: 20-36.
56. Alpert NR, Mulieri LA, Warshaw D. The failing human heart. Cardiovasc Res 2002; 54: 1-10.
57. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-85.
58. Sanbe A, Nelson D, Gulick J, Setser E, Osinska H, Wang X, et al. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res 2000; 87: 296-302.
59. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyophathy. J Mol Cell Cardiol 2001; 33: 655-70.
60. Burton D, Abdulrazzak H, Knott A, Elliott K, Redwood C, Watkins H, et al. Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility. Biochem J 2002; 362: 443-51.
61. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280: 750-2.
62. Ferasin L, Sturgess CP, Cannon MJ, Caney SM, Gruffydd-Jones TJ, Wotton PR. Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994-2001). J Feline Med Surg 2003; 5: 151-9.
63. Rappezzi CP, Ortolanti, Binetti G, Picchio FM, Magnani B. Idiopathic restrictive cardiomyopathy in the young: report of two cases. Int J Cardiol 1990; 29: 121-6.
64. Gewilling M, Mertens L, Moerman P, Dumoulin M. Idiopathic restrictive cardiomyopathy in childhood. A diastolic disorder characterized by delayed relaxation. Eur Heart J 1996; 17: 1413-20.
65. Zachara E, Bertini E, Lioy E, Boldrini R, Prati PL, Bosman C. Restrictive cardiomyopathy due to desmin accumulation in a family with evidence of autosomal dominant inheritance. G Ital Cardiol 1997; 27: 436-42.
66. Schwartz ML, Colan SD. Familial restrictive cardiomyopathy with skeletal abnormalities. Am J Cardiol 2003; 92: 636-9.
67. Palka P, Lange A, Ward C. A fatal case of idiopathic restrictive cardiomyopathy. Cardiol Young 2003; 13: 469-71.
68. Ligi I, Fraisse A, Chabrol B, Paul O, Bourlon F, Metras D, et al. Restrictive cardiomyopathy due to myofibrillar myopathy. Arch Pediatr 2003; 10: 432-5.
69. Zhang J, Kumar A, Stalker HJ, Virdi G, Ferrans VJ, Horiba K, et al. Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy. Clin Genet 2001; 59: 248-56.
70. Mogensen J, Hubo T, Duque M, Uribe W, Shaw A, Murphy R, et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest 2003; 111: 209-16.
71. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379-82.
72. Mogensen J, Klausen IC, Egeblad H. Sudden cardiac death in familial hypertrophic cardiomyopathy is associated with a novel mutation in the troponin I gene. Circulation 1999; 100 (Suppl): I-618.
73. Deng Y, Schmidtmann A, Redlich R, Westerdorf B, Jaquet K, Thieleczek R. Effects of phosphorylation and mutation R145G on human cardiac troponin I function. Biochemistry 2001; 40: 14593-602.